Zentalis Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Zentalis Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q3 2024.
  • Zentalis Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 71.1M shares, a 0.71% increase year-over-year.
  • Zentalis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 65.4M shares, a 23.7% increase from 2022.
  • Zentalis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52.9M shares, a 23.8% increase from 2021.
  • Zentalis Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 42.7M shares, a 51.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 71.1M +499K +0.71% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 71M +10.3M +16.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 70.9M +11.6M +19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 65.4M +12.6M +23.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 70.6M +13.8M +24.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 60.8M +9.67M +18.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 59.3M +14M +31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 52.9M +7.88M +17.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 56.8M +12.2M +27.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 51.1M +10.4M +25.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 45.2M +4.89M +12.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 45M +5.04M +12.6% Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 44.6M +6.65M +17.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 40.7M +6.39M +18.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 40.4M +34.8M +621% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 39.9M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 38M Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 34.4M Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 5.6M Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.